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ABSTRACT 
Currently, magnetic iron oxide nanoparticles are the only nano-sized magnetic resonance imaging 
(MRI) contrast agents approved for clinical use, yet commercial manufacturing of these agents has been 
limited or discontinued. Though there is still widespread demand for these particles both for clinical use 
and research, they are difficult to obtain commercially, and complicated syntheses make in-house 
preparation infeasible for most biological research labs or clinics. To make commercial production viable 
and increase accessibility of these products, it is crucial to develop simple, rapid, and reproducible 
preparations of biocompatible iron oxide nanoparticles. Here, we report a rapid, straightforward 
microwave-assisted synthesis of superparamagnetic dextran-coated iron oxide nanoparticles. The 
nanoparticles were produced in two hydrodynamic sizes with differing core morphologies by varying the 
synthetic method as either a two-step or single step process. A striking benefit of these methods is the 
ability to obtain swift and consistent results without the necessity for air, pH, or temperature sensitive 
techniques; therefore, reaction times and complex manufacturing processes are greatly reduced as 
compared to conventional synthetic methods. This is a great benefit for cost-effective translation to 
commercial production. The nanoparticles are found to be superparamagnetic and exhibit properties 
consistent for use in MRI. In addition, the dextran coating imparts the water-solubility and 
biocompatibility necessary for in vivo utilization.  
KEYWORDS: microwave-assisted synthesis, iron oxide nanoparticles, superparamagnetism, MRI 
contrast agent, dextran-coating 
Iron oxide particles have been widely studied for commercial applications in magnetic storage 
media, catalysis, magnetic inks, pigments, ferrofluid seals, biotechnology, and medical diagnostics.1 In 
particular, advances in the fabrication of nanosized magnetic particles has led to novel and rapidly 
evolving uses in biomedical applications such as cell tracking and separation, hyperthermia treatment, 
immunoassays, drug delivery vehicles, and magnetic resonance imaging (MRI) contrast agents.1-3 For 
such applications in vivo, the ideal iron oxide nanoparticles should exhibit a small size (< 100 nm) with 
minimal polydispersity, a nontoxic, biocompatible surface coating, and high magnetization in the 
presence of a magnetic field. Development of superparamagnetic iron oxide nanoparticles (SPIO) with a 
variety of differing cores and surface coatings for molecular imaging has resulted in numerous contrast 
agents that are currently in commercial use or under clinical investigation.2,4 Yet, consistency of 
successful preparations that are time-, energy-, and cost-efficient is always of concern. 
 The scientific literature presents a plethora of techniques to prepare magnetic iron oxide 
nanoparticles including coprecipitation,5-15 thermal decomposition,16-19 sonolysis,20-24 electrochemical 
deposition,25 sol-gel processes,26-28 spray and laser pyrolysis,29-31 flow injection synthesis,32 hydrothermal 
and high temperature syntheses,33-38 and nanoreactors such as protein cages,39-42 vesicles,43,44 and 
microemulsions45-48. While each of these methods may enjoy certain advantages depending on the desired 
properties of the iron oxide nanoparticles, many of them possess severe disadvantages for clinical 
translation such as the necessity for costly, specialized equipment, low yielding, excessively complicated 
synthetic schemes, and uncontrollable or inconsistent results. An example of a circumstance where 
manufacturing process vs. cost was critical, is in the case of Feridex®, the only U.S. FDA approved SPIO 
MRI contrast agent. Feridex® was approved by the FDA in 1996 and likewise, obtained approval in 
overseas markets as well. Despite worldwide distribution and use of this SPIO contrast agent, Feridex® is 
no longer being marketed by its proprietary owner and lone manufacturer, AMAG Pharmaceutical, Inc. 
The company announced on their website that production of the contrast agent was halted in November 
2008. Though a reason was not specified, one can infer that the company’s net profits from Feridex® 
were not sufficient to continue commercial manufacture of the agent. Perhaps more time- and cost-
efficient production would have changed this outcome. 
By far, the most common and classically used method for synthesis of SPIO is coprecipitation of 
Fe3+ and Fe2+ salts in a basic medium.4 The coprecipitation method offers some advantages in that a large 
quantity of particles may be prepared and the size, shape, and composition of the nanoparticles can be 
modified depending upon the ratio and type of iron salts used, the reaction pH, and the ionic strength of 
the medium.49-53 In addition, researchers have demonstrated the ability to apply surface coatings to the 
particles both during and following the coprecipitation process. Nonetheless, a major drawback of this 
method is limited control of size distribution.4,54,55 Despite the ease and efficiency of coprecipitation, 
extensive purification or size sorting may be necessary.2,56 For surfactant stabilized particles, Perales-
Perez and colleagues used physicochemical methods to effectively select 4-7nm magnetite particles from 
polydisperse powder with sizes ranging from 4-40nm.57 For polymer coated particles, Rheinlander et al. 
demonstrated using flow field-flow fractionation to sort a 10-50nm mixture of dextran-coated iron oxide 
particles into approximately 8 different batches according to size.58 Magnetic properties vary depending 
on nanoparticle size; therefore, the ability to control the dispersity of a sample is crucial.59 Several 
methods have been proposed for particle size sorting in recent years, including common physical 
processes such as ultracentrifugation, microfiltration, or size exclusion chromatography.57,60 Also, size 
sorting may be performed by adding an electrolyte solution to the particle solution to disrupt its stability 
and cause precipitation of large particles.61 Less common methods such as magnetic chromatography56 
have also been explored. Each of these methods lengthens and complicates the synthetic process and 
reduces the yield of the desired product. As a result, researchers are seeking new means that offer even 
greater advantages without the inherent shortcomings of the current methodology. A potential answer lies 
in the emergent microwave synthesis technology. 
 Microwave-assisted synthesis has been utilized since the late 1980s in the preparation of organics, 
organometallics, and peptides.62 Just in the last decade, exploration of this methodology for inorganic 
material synthesis has been gaining momentum. Microwave synthesis has been shown to significantly 
reduce reaction time, increase yields, reduce side reactions, enhance reproducibility, and provide a more 
energy efficient, greener process.62,63 Microwave heating presents significant benefits over traditional 
heating methods (i.e. oil bath), which rely on conduction and convection for heat distribution. Microwave 
radiation heats materials through much more efficient dielectric heating; this occurs as molecular dipoles 
attempt to align with the alternating electric field. Thus, the heating phenomenon depends on a 
substance’s ability to absorb microwaves and convert the energy to heat; generally, more polar solvents, 
reagents, and catalysts are more efficiently heated. Beyond the previous noted benefits, in the case of 
nanoparticle synthesis, microwave preparation has yielded greater control of size and dispersity as well as 
enhanced crystallinity.64 
 Microwave syntheses for superparamagnetic iron oxide nanoparticles have been reported that 
yield Fe2O3 particles65-68, mixed Fe2O3 and Fe3O4 particles69, and Fe3O4 particles67,70-74.  Only a small 
fraction of those reported indicate passivation of the nanoparticle surface, which is necessary for water 
solubility and biocompatibility. In 2007, Zhu and coworkers reported microwave synthesis of irregular 
shaped Fe3O4 nanoparticles and ellipsoidal Fe2O3 nanoparticles that were coated with polyethylene glycol 
(PEG-20000).67 In 2009, Yang et al published the microwave synthesis of spherical, nanoporous Fe3O4 
nanoparticles also coated with PEG.71 In 2010, Edrissi and colleague reported the microwave-assisted 
synthesis of spheroid Fe2O3 nanoparticles coated with linoleic or palmitoleic acid.74 To date, no 
microwave methods to prepare dextran-coated iron oxide nanoparticles have been reported. 
 Dextran is an abundant, inexpensive polymer that consists solely of alpha-D-glucopyranosyl 
monomers. The polysaccharide has a large number of hydroxyl groups that foster chelation and hydrogen-
bonding interactions with iron oxide surfaces as well as provide locations for modification.2 Dextran 
coating provides stability and biological compatibility to the iron oxide nanoparticles, thereby making 
them suitable MRI contrast agents.4 Due to their superior biocompatibility properties, this platform is a 
common motif for MR T2 agents. Previous pharmacokinetic studies have established that dextran-coated 
iron oxide nanoparticle are sequestered by the reticuloendothelial system and metabolized to molecular 
iron for incorporation into hemoglobin within 5-40 days.75,76 Herein, we report the synthesis of 
superparamagnetic dextran-coated iron oxide nanoparticles by two separate microwave heating methods. 
In varying the synthetic strategy by either a two-step or single step process, we were able to consistently 
obtain iron oxide nanoparticles in two size regimes. The resulting nanoparticles were characterized with 
transmission electron microscopy (TEM), dynamic light scattering (DLS), powder X-ray diffraction 
(XRD), Fourier transform infrared spectroscopy (FT-IR), inductively coupled plasma mass spectrometry 
(ICP-MS), vibrating sample magnetometry (VSM), superconducting quantum interference device 
(SQUID) magnetometry and magnetic resonance relaxometry. 
RESULTS AND DISCUSSION 
Microwave-assisted synthesis of dextran-coated iron oxide nanoparticles (DIO) was successfully 
accomplished by two methods. In the first approach, the nanoparticles were synthesized via a two-step 
reaction. First, uncoated iron oxide nanoparticles, basically iron cores with no coating, were prepared by 
hydrazine reduction of ferric chloride with microwave heating at 100C for 10 minutes. Subsequent 
coating of the nanoparticles with dextran was achieved in a second stage of microwave heating at 100C 
for 2 minutes in the presence of additional ferric chloride, sodium hydroxide, and reduced dextran. The 
coating step was more challenging than first anticipated, as numerous attempts were unsuccessful. The 
initial trials, comprising reactions of either reduced dextran with bare nanoparticles or reduced dextran 
with bare nanoparticles in acidic or basic conditions, resulted in large aggregates of particles that quickly 
fell out of solution. Successful dextran coating was finally achieved by inclusion of an additional 400 L 
of 1.0M ferric chloride in the second coating step. Presumably, the Fe3+ ions associate with the 
nanoparticle surface and function to provide a charged particle shell, thus sustaining the particle 
dispersion in aqueous solution and encouraging dextran passivation.77 In the second synthetic approach, 
the nanoparticles were synthesized in a one-pot single step microwave reaction. Ferric chloride and 
reduced dextran were reacted with hydrazine in the microwave at 100C for 10 minutes. The two methods 
result in different sized nanoparticles. 
TEM was used to characterize the size and shape of the iron oxide cores. TEM images in Figure 1 
demonstrate the differing morphology obtained with the different synthetic schemes. The single step 
synthesis resulted in relatively monodisperse particles with an iron core size of 6.5 ± 1.2 nm. In contrast, 
two-step synthesis results in larger size particles with the iron oxide cores measuring 18.0 ± 4.1 nm in a 
mixture of shapes ranging from spheroid to cubes. Predictably, the dextran coating step did not change the 
observed core size as uncoated particles after step 1 similarly measured 17.7 ± 6.6 nm (Fig. 1b). However, 
the shape has changed and the large square looking particles are noticeably missing from the TEM image. 
The histograms beneath each image in Figure 1 provide a look at the entire population distribution of the 
nanoparticle core diameters used to calculate the mean size ± one standard deviation. Dynamic light 
scattering (DLS) was used to determine the hydrodynamic size of the particles in aqueous solution. While 
the dextran coating is translucent to TEM, the DLS measurement provides the size of the particles with 
coating included. The two-step synthesis produced nanoparticles with an overall hydrated diameter of 67 
± 17 nm, while the single step method yielded 39 ± 8 nm particles. These DLS results are consistent with 
values previously obtained in our lab for dextran coating thickness and iron core size with conventional 
heating methods.78-80 Therefore, compared with synthetic methods that yield wide size ranges, there is 
promising efficiency for production by the microwave method. In this case, on average, 85% of the one-
step product is between 30-50 nm and 62% of the two-step product is 50-80 nm in size. In addition, the 
reduced reaction time and reduced complexity of the technique make it an attractive alternative. 
Furthermore, the smaller iron core size for nanoparticles formed while dextran is in situ versus subsequent 
addition has been reported in literature.81-83 Dextran is thought to limit the growth of the iron oxide core 
by confining the space available for crystal growth. At high dextran concentration, the randomly folded 
polymer provides small spaces for nanoparticle nucleation and growth that is halted upon dextran 
adsorption to the iron oxide surface.82,83  
 
 The crystal structures of representative samples of the dextran-coated and uncoated nanoparticles 
were analyzed by powder X-ray diffraction (XRD). Though line broadening slightly obscures the 
precision of the diffraction patterns, the line position and intensity features (Fig. 2) were consistent with 
the spinel phases of magnetite (Fe3O4) and/or maghemite (-Fe2O3). These two phases are not 
distinguishable from the obtained XRD patterns; therefore, we suggest that the product may contain either 
or both of these iron oxide phases. The reference peaks for magnetite and maghemite are provided (in Fig. 
2d/e) for comparison to the prepared nanoparticles. The line broadening observed for XRD patterns of 
nanosized crystalline particles results from diffraction of X-rays over volumes with size analogous to the 
Figure 1. Representative TEM images of (a) one-pot synthesized dextran-coated iron oxide
nanoparticles (DIO) with an iron oxide core measuring 6.5 ± 1.2 nm, (b) uncoated iron oxide
nanoparticles (obtained after step 1 of the two-step synthesis) with a core diameter of 17.7 ± 6.6
nm, and (c) two-step DIO with a core diameter of 18.0 ± 4.1 nm. Scale bar = 50 nm. The
histograms included below each image indicate the population size distributions for three batches
of each, respectively. 
 
X-rays wavelength.84 This effect allows for calculation of the crystallite size using the Scherrer equation 
assuming one product and a Gaussian size distribution. Calculation of the crystallite sizes yielded 4.3 nm 
± 0.2 (whole pattern fitting assuming all Fe3O4) for the one-step iron oxide, and this is slightly smaller 
than that determined by TEM. The powder diffraction patterns of the uncoated iron oxide nanoparticles 
and the two-step DIO product show reflections that are composed of a broad base indicative of small 
particles superimposed with a narrow peak indicative of much larger particles, consistent with the large 
size distribution observed in the TEM.  This is especially apparent for the powder diffraction of the two-
step DIO. Whole pattern fitting is only appropriate for obtaining the average crystallite size when the 
samples are fairly uniform. While the average crystallite size is consistent with the TEM for the one-step 
method, in the case of the uncoated particles and two-step DIO, crystallite size from powder X-ray 
diffraction would be misleading because of the very large size distribution observed in the TEM.  
 
Percent iron content for the DIO nanoparticles was determined by ICP-MS in order to allow 
calculation of magnetic properties per mass of iron. Given the percent of iron per mass of sample, the 
Figure 2. XRD patterns for (a) one-step DIO, (b) uncoated
iron oxide particles (obtained after step 1 of the two-step
synthesis), (c) two-step DIO, and reference patterns for (d)
Fe3O4 PDF #65-3107 and (e) -Fe2O3 PDF # 25-1402. 
a) 
b) 
c) 
d) 
e) 
magnetization of the particles was evaluated by VSM and plotted with respect to the amount of iron 
(emu/gram of Fe). Room temperature magnetic hysteresis loops of dextran-coated iron oxides are shown 
in Fig. 3.  For the one-step synthesis, the sample is superparamagnetic with no hysteresis (Fig. 3a). On the 
contrary, a small ferromagnetic component was observed for the two-step product (Fig. 3b), consistent 
with the larger iron oxide core observed by TEM. Notably, small but appreciable remanent magnetization 
only appeared after the dextran coating step for the two-step synthesis; the magnetization curve for the 
uncoated nanoparticles after step 1 of the two-step synthesis (not shown) was similar to that of the one-
step product with no hysteresis. The dextran coating step likely caused further grain growth, albeit small, 
that pushed the superparamagnetic blocking temperature above room temperature.  
 
The temperature dependence of the magnetization was analyzed by SQUID magnetometry.  For 
the one-step DIO sample, the zero-field-cooled (ZFC) curve displays a maximum in the temperature 
dependence of the magnetization, corresponding to a blocking temperature of ~25 K (Fig. 4a).   In 
comparison, the two-step DIO sample is ferromagnetic at room temperature.  Saturation magnetization at 
10 K for the one-step and two-step sample is 71 emu/gFe (Fig. 4b) and 42 emu/gFe, respectively.  
Following the method laid out in Cho et al.,85,86 from the blocking temperature, we estimate the size of the 
one-step particles to be 5.7 nm, consistent with the TEM imaging.  Similarly, the size of the two-step 
a) b) 
Figure 3. Room temperature magnetic hysteresis loops of (a) one-step iron oxide 
nanoparticles and (b) two-step iron oxide nanoparticles with an inset showing the small 
hysteresis loop, indicating a ferromagnetic component.  
particles is >13 nm, again consistent with TEM measurements. Despite the larger iron oxide core, the 
two-step microwave prepared particles exhibited lower magnetization suggesting the potential presence of 
phases that are less magnetic. In literature, reduced magnetization due to surface characteristics and 
coatings has also been observed and attributed to several mechanisms, including spin-canting at the 
particle surface or a surface layer that is magnetically ineffective.3 Further examination beyond the scope 
of this paper is required to illuminate the effect of the nanoparticle surface coating on magnetization.  
Infrared spectroscopy (IR) confirmed the presence of dextran coating as revealed by comparison 
of both uncoated and dextran coated iron oxide nanoparticles (Figure 5). The uncoated nanoparticles 
(red), obtained after step 1 of the two-step synthesis, display the Fe-O vibration band at 586cm-1. 
Following the addition of dextran, characteristic absorption bands for hydroxyl at 3387cm-1(broad), C-O 
at 1018cm-1, and C-H at 2932cm-1 were observed for both the one- (blue) and two-step (green) dextran 
coated nanoparticles, while the Fe-O band was slightly obscured. In concurrence with the measured 
hydrodynamic size, these results further verified the coating of dextran onto the iron oxide nanoparticles. 
Figure 4. Temperature dependence of magnetization of the one-step dextran-coated 
iron oxide nanoparticles measured in a 10 Oe external field, (a) ZFC (black squares) 
and FC (red circles) curves and (b) magnetic hysteresis loop at 10 K, normalized to the 
mass % of Fe.  
a) b)
Relaxivity, a concentration-independent measure of the effectiveness of a paramagnetic material, 
was determined as the slope of inverse relaxation time versus iron concentration. Superparamagnetic iron 
oxide nanoparticles are commonly considered T2 contrast agents due to their high transverse relaxivities.2 
Longitudinal and transverse relaxation time of aqueous iron oxide nanoparticle samples were measured at 
60 MHz and 37 C. Table 1 includes the calculated relaxivities for the two iron oxide microwave 
preparations. The one-step product yielded an r2 relaxivity of 58.1 ± 3.0 mM-1 s-1 while the two-step DIO 
was 39.3 ± 7.4 mM-1 s-1. While we initially expected the larger core nanoparticles to produce the greater 
relaxivity, these results are consistent with the magnetization data in which the two-step particles generate 
smaller magnetization. As a reference, the formerly commercially manufactured SPIO, Feridex®, was 
reported to have an r1 of 10.1 mM-1 s-1 and an r2 of 120 mM-1 s-1 at 1.5 T field strength.2 Though the 
relaxivity of Feridex® is roughly twice that of our one-pot DIO, the wide size distribution of Feridex® 
(60-150nm) is not ideal for uniform biodistribution. 
 
 
Figure 5. IR spectra of one-step iron oxide nanoparticles  (B, blue), two-step iron
oxide nanoparticles  (A, green), and uncoated IO particles (C, red). 
A 
B 
C 
Table 1. Longitudinal and Transverse Relaxivity of Dextran-coated Iron Oxide Nanoparticles 
 r1 (mM-1 s-1) r2 (mM-1 s-1) 
Two-step DIO  2.3 ± 0.3 39.3 ± 7.4 
One-step DIO  7.8 ± 0.3 58.1 ± 3.0 
 
CONCLUSIONS 
 In conclusion, this work describes two methods for the microwave-assisted synthesis of 
superparamagnetic dextran coated iron oxide nanoparticles. These simple and rapid preparations allow for 
consistent synthesis of dextran-coated iron oxide nanoparticles without the necessity for techniques such 
as prior chilling or degassing of reagents, strict pH control, or use of Schlenk line. Therefore, reaction 
times and complex manufacturing processes are greatly reduced, and the majority of the product is in a 
desirable size range, as compared to conventional synthetic methods. This is of utmost importance for 
cost-effective translation to commercial production. Based on the results described herein, the single-step, 
one-pot microwave synthesis shows greater promise over the two-step method as a rapid and consistent 
method to produce iron oxide nanoparticles for MRI. The one-step method yields dextran passivated iron 
oxide nanoparticles that are fairly monodisperse and of favorable size (hydrodynamic diameter of ~39 nm 
and 85% of particles are 30-50 nm in size) to allow longer blood retention; also, its magnetization and 
relaxivity profiles are superior to that of the two-step product. In future work, we will determine what 
effect a change in synthetic parameters, such as stoichiometry or microwave reaction time and 
temperature, will have on the agent’s morphology and MR characteristics.  
Microwave synthesis of iron oxide nanoparticles offers exciting possibilities for rapid production 
of clinically relevant contrast agents and the ability to rapidly explore new platforms (i.e. Core-shell, 
doped, etc.) for future MR contrast agents with nearly instant results. In addition, in our previously 
published work, we have demonstrated the ability to modify dextran coatings to allow for further 
functionalization or targeting ability.78-80,87 Thus, the potential to develop these nanoparticles, beyond 
blood-pool agents, into activatable MRI contrast agents is within reach. 
MATERIALS AND METHODS 
General 
All reagents were purchased from commercial sources and used without further purification. Nanopure 
water (18.0 Mcm) from a Barnstead nanopure filtration unit was used throughout experiments. 
Microwave synthesis was carried out in a Discover SP/Explorer-12 Automated Microwave Synthesis 
System (CEM Corporation, USA) using glass microwave reaction vessels with Teflon caps purchased 
from CEM Corp. The temperature of each microwave reaction was precisely controlled by the Discover 
system; however, the reaction pressure was not controlled beyond setting the maximum at 250psi and 
allowing the vessels to self-vent as needed. FT-IR spectra were obtained using a Shimadzu IR Prestige 21 
equipped with a diffuse reflectance accessory. Lyophilized nanoparticle powder was mixed with KBr, and 
the measurements were performed under ambient conditions. 
Two-step synthesis of dextran-coated iron oxide particles (DIO) 
a. Step 1: Preparation of uncoated iron oxide nanoparticles. In a typical microwave synthesis, ferric 
chloride (FeCl3  6 H2O, 78 mg) was dissolved in 8 mL of water in a 35 mL microwave reaction vessel 
equipped with a stir bar. Immediately prior to microwave heating, hydrazine hydrate (N2H4  H2O, 1 mL) 
was added to the vessel at room temperature with stirring.67 The mixture was heated by microwave at 100 
± 5 C for 10 min (300W max power, 250psi max pressure) with rapid stirring. The black product was 
collected by centrifugation, washed with water five times, and carried forward to step 2 or freeze-dried to 
yield a black crystalline powder.  
b. Step 2: Dextran coating of particles. In preparation for dextran coating, the dextran (10,000 MW) was 
reduced with sodium borohydride according to a literature method.88 Briefly, an aqueous solution of 
dextran was stirred with sodium borohydride (26 equivalents) at room temperature for 12 h. The reaction 
was stopped by the dropwise addition of conc. HCl until pH 7 and then the reduced dextran was dialysed 
(Spectra/Por 6, MWCO 10,000) against nanopure water. The dextran was applied to freshly prepared 
uncoated iron oxide particles following the water washings. Reduced dextran (100 mg) was dissolved in 
an aqueous nanoparticle suspension (5 mL) by sonication. Then, 1.0 M ferric chloride (400 L) and 1.0 M 
NaOH (1.0 mL) were added to the mixture preceding microwave heating at 100 C for 2 min. The 
resulting solution was purified by membrane dialysis (Spectra/Por 6, MWCO 15,000) against nanopure 
water and freeze-dried to yield a brown crystalline solid. 
Single step, one pot preparation of dextran-coated iron oxide particles (DIO) 
Dextran coated iron oxide nanoparticles were synthesized in a single step by a microwave method similar 
to the uncoated nanoparticles described above. Ferric chloride (76 mg) and reduced dextran (100 mg) 
were dissolved in 8 mL of water with stirring in a 35 mL microwave reaction vessel. The ratio of 
dextran:Fe used (1:27) was chosen based on our previous experience in dextran coating preparation.79,80 
Immediately prior to microwave heating, hydrazine hydrate (1 mL) was added to the vessel at room 
temperature with stirring. The mixture was heated by microwave at 100 ± 5 C for 10 min with rapid 
stirring. The product could not be collected by centrifugation due to increased stability in aqueous media. 
The black solution was purified by membrane dialysis (Spectra/Por 6, MWCO 15,000) against nanopure 
water and freeze-dried to yield a brown crystalline solid. 
Characterization of size, iron content, and crystalline structure 
Hydrated particle size was determined by dynamic light scattering (DLS) on a Nanotrac 150 particle size 
analyzer (Microtrac, Inc., Montgomeryville, PA). A geometric eight-root regression, with no residuals, 
was used to fit the data. The Nanotrac 150 has a built-in thermometer to measure the cell temperature, 
from which the viscosity is calculated; the nanorange option was enabled and scan time of three times 30 
s was used. Particle size is expressed as the mean diameter ± one standard deviation. Transmission 
electron microscopy (TEM) images were utilized to determined iron oxide core size and shape (Phillips 
CM120, operating at 80kV and equipped with a Gatan Megascan digital camera). Sample solution was 
dropped onto carbon-coated 300 mesh copper grids. Core particle diameter was determined by taking the 
mean diameter of at least 300 particles for 3 separate syntheses as measured from TEM images in Image J 
software (National Institutes of Health). Iron content was determined by inductively coupled plasma mass 
spectrometry (ICP-MS) (Agilent Technologies 7500ce). The samples were prepared by digestion in 3% 
nitric acid. Powder X-ray diffraction (XRD) patterns were obtained on a Bruker D8 Advance X-ray 
diffractometer with Cu Kα radiation (1.5418 Å). The diffraction patterns were collected between 20° < 2θ 
< 68 with a Time/Step of 1.61 s and a step size of 0.006 (2θ). Data were analyzed with MDI Jade Plus 
6.1.1 software. Average crystallite size was determined by the Whole Profile Fitting within the MDI Jade 
suite of programs for the freeze-dried product from the one-step synthesis. The other products were 
analyzed for crystallite size by the Scherrer equation for the (hkl) peak. 
Magnetic Measurements 
A Princeton Measurement Corp. MicroMag vibrating sample magnetometer (VSM) and a Quantum 
Design superconducting quantum interference device (SQUID) magnetometer were used to evaluate the 
magnetic properties of the iron oxide nanoparticle samples. The lyophilized nanoparticle powders were 
prepared by first measuring their mass, then placing each in a gel-cap with cotton stopper.  The gel-cap 
was mounted on a quartz rod for insertion to the VSM.  Each measurement was conducted in a field range 
of ±1.8T, with variable step size down to 2 Oe near remnance and a measurement time of 0.1 sec.  
Background measurements of the gel-cap plus stopper were conducted and found to be < 3% of the signal 
from the powders. A SQUID magnetometer was used to measure the zero-field-cooled (ZFC) and field-
cooled (FC) temperature dependence of the magnetization in an external field of 10 Oe, as well as 
magnetic hysteresis loops at low temperatures (measurement time ~30s).  
Relaxometry 
Longitudinal (T1) and transverse (T2) relaxation times were measured on a Bruker Minispec mq60 
relaxometer (Billerica, MA) at 60 MHz and 37 C. T1 values were measured using an inversion recovery 
sequence with 10–15 data points, and T2 was measured using a Carr–Purcell–Meiboom–Gill (CPMG) 
sequence with τ = 1 ms, and 200 data points. Longitudinal and transverse relaxivity was determined as the 
slope of the line for plots of 1/T1 or 1/T2, respectively, against increasing iron concentration with a 
correlation coefficient greater than 0.99. 
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